817 related articles for article (PubMed ID: 23790596)
1. Assessment of anticoagulation intensity and management of bleeding with old and new oral anticoagulants.
Liew A; Eikelboom JW; O'Donnell M; Hart RG
Can J Cardiol; 2013 Jul; 29(7 Suppl):S34-44. PubMed ID: 23790596
[TBL] [Abstract][Full Text] [Related]
2. Periprocedural management of oral anticoagulation in patients with atrial fibrillation: approach in the era of new oral anticoagulants.
Healey JS; Brambatti M
Can J Cardiol; 2013 Jul; 29(7 Suppl):S54-9. PubMed ID: 23790599
[TBL] [Abstract][Full Text] [Related]
3. Updated guidelines on outpatient anticoagulation.
Wigle P; Hein B; Bloomfield HE; Tubb M; Doherty M
Am Fam Physician; 2013 Apr; 87(8):556-66. PubMed ID: 23668445
[TBL] [Abstract][Full Text] [Related]
4. [Has the era of warfarin terminated?].
Pavlova TV; Dupliakov DV; Kuzina TN
Angiol Sosud Khir; 2014; 20(1):16-20. PubMed ID: 24722016
[TBL] [Abstract][Full Text] [Related]
5. Management of Major Bleeding in Patients With Atrial Fibrillation Treated With Non-Vitamin K Antagonist Oral Anticoagulants Compared With Warfarin in Clinical Practice (from Phase II of the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF II]).
Steinberg BA; Simon DN; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Kowey PR; Mahaffey KW; Peterson ED; Piccini JP;
Am J Cardiol; 2017 May; 119(10):1590-1595. PubMed ID: 28363354
[TBL] [Abstract][Full Text] [Related]
6. Importance of pharmacokinetic profile and variability as determinants of dose and response to dabigatran, rivaroxaban, and apixaban.
Gong IY; Kim RB
Can J Cardiol; 2013 Jul; 29(7 Suppl):S24-33. PubMed ID: 23790595
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of discontinuing rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: analysis from the ROCKET AF trial (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation).
Patel MR; Hellkamp AS; Lokhnygina Y; Piccini JP; Zhang Z; Mohanty S; Singer DE; Hacke W; Breithardt G; Halperin JL; Hankey GJ; Becker RC; Nessel CC; Berkowitz SD; Califf RM; Fox KA; Mahaffey KW
J Am Coll Cardiol; 2013 Feb; 61(6):651-8. PubMed ID: 23391196
[TBL] [Abstract][Full Text] [Related]
8. Management of bleeding with oral anticoagulants in patients with atrial fibrillation.
Bosch J; Eikelboom JW
Hamostaseologie; 2015; 35(4):351-7. PubMed ID: 26013362
[TBL] [Abstract][Full Text] [Related]
9. Warfarin in non-valvular atrial fibrillation.
Dalby AJ; Wessels P; Opie LH
S Afr Med J; 2013 Oct; 103(12):901-4. PubMed ID: 24300625
[TBL] [Abstract][Full Text] [Related]
10. Practical management of bleeding in patients receiving non-vitamin K antagonist oral anticoagulants.
Weitz JI; Pollack CV
Thromb Haemost; 2015 Nov; 114(6):1113-26. PubMed ID: 26155974
[TBL] [Abstract][Full Text] [Related]
11. Personalizing oral anticoagulant treatment in patients with atrial fibrillation.
Capranzano P; Miccichè E; D'Urso L; Privitera F; Tamburino C
Expert Rev Cardiovasc Ther; 2013 Aug; 11(8):959-73. PubMed ID: 23957907
[TBL] [Abstract][Full Text] [Related]
12. Management of oral anticoagulant treatment in patients with venous thromboembolism.
Pengo V
Semin Thromb Hemost; 2006 Nov; 32(8):781-6. PubMed ID: 17171590
[TBL] [Abstract][Full Text] [Related]
13. Meta-analysis: effect of patient self-testing and self-management of long-term anticoagulation on major clinical outcomes.
Bloomfield HE; Krause A; Greer N; Taylor BC; MacDonald R; Rutks I; Reddy P; Wilt TJ
Ann Intern Med; 2011 Apr; 154(7):472-82. PubMed ID: 21464349
[TBL] [Abstract][Full Text] [Related]
14. New oral anticoagulants in development.
Weitz JI
Thromb Haemost; 2010 Jan; 103(1):62-70. PubMed ID: 20062934
[TBL] [Abstract][Full Text] [Related]
15. Oral antithrombotic therapy in atrial fibrillation associated with acute or chronic coronary artery disease.
Cairns JA; McMurtry MS
Can J Cardiol; 2013 Jul; 29(7 Suppl):S60-70. PubMed ID: 23790600
[TBL] [Abstract][Full Text] [Related]
16. EHRA practical guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation: executive summary.
Heidbuchel H; Verhamme P; Alings M; Antz M; Hacke W; Oldgren J; Sinnaeve P; Camm AJ; Kirchhof P
Eur Heart J; 2013 Jul; 34(27):2094-106. PubMed ID: 23625209
[TBL] [Abstract][Full Text] [Related]
17. Home-monitoring of oral anticoagulation vs. dabigatran. An indirect comparison.
Alonso-Coello P; Zhou Q; Guyatt G
Thromb Haemost; 2012 Oct; 108(4):647-53. PubMed ID: 22918481
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of warfarin in paediatric patients with prosthetic cardiac valves: a retrospective audit.
Wong CS; Batchelor K; Bua J; Newall F
Thromb Res; 2011 Oct; 128(4):331-4. PubMed ID: 21620442
[TBL] [Abstract][Full Text] [Related]
19. Variability of INR and its relationship with mortality, stroke, bleeding and hospitalisations in patients with atrial fibrillation.
Lind M; Fahlén M; Kosiborod M; Eliasson B; Odén A
Thromb Res; 2012 Jan; 129(1):32-5. PubMed ID: 21851969
[TBL] [Abstract][Full Text] [Related]
20. Intensity of anticoagulation with warfarin and risk of adverse events in patients presenting to the emergency department.
Anthony CJ; Karim S; Ackroyd-Stolarz S; Fry A; Murphy NG; Christie R; Zed PJ
Ann Pharmacother; 2011 Jul; 45(7-8):881-7. PubMed ID: 21750309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
